Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6397 USD | -0.20% | -0.91% | -14.20% |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.20% | 13.49M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+47.19% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Onconova Therapeutics, Pangea Biomed Collaborate to Identify Biomarkers of Response to Rigosertib